Background and Purpose-Initial reports indicate that transcranial harmonic imaging after ultrasound contrast agent bolus injection (BHI) can detect cerebral perfusion deficits in acute ischemic stroke. We evaluated parametric images of the bolus washout kinetics. Methods-Twenty-three patients with acute internal carotid artery infarction were investigated with perfusion harmonic imaging after SonoVue bolus injection Յ40 hour after the onset of symptoms. The findings were compared with those of cranial computed tomography (CCT) and clinical course 4 months after stroke. Results-Images of pixel-wise peak intensity (PPI) and time to peak intensity could be calculated for all patients. Spearman rank correlations of rϭ0.772 (PϽ0.001) and rϭ0.572 (Pϭ0.008) between area of PPI signal decrease and area of infarction in the follow-up CCT as well as outcome after 4 months were obtained, respectively. Conclusions-In the early phase of acute ischemic stroke, BHI after SonoVue bolus injection is a useful ultrasound tool for analyzing cerebral perfusion deficits at the patient's bedside. BHI data correlate with the definite area of infarction and outcome after 4 months. Key Words: ultrasonography Ⅲ stroke Ⅲ contrast media I n patients with acute cerebral ischemia, brain perfusion can be analyzed by several diagnostic methods, such as computed tomography (CT), magnetic resonance tomography, single-photon emission computed tomography, and positron emission tomography. Ultrasound, as a less time-consuming, inexpensive, and well-tolerated bedside method for critically ill patients, has been introduced for the evaluation of brain perfusion. 1-4 By using transcranial harmonic imaging, it is possible to track an ultrasound contrast agent bolus within the human cerebral microcirculation. This technology is called bolus perfusion harmonic imaging (BHI). Initial reports have indicated that this harmonic imaging technique may be useful in assessing pathologic brain perfusion. [5][6][7][8][9] The purpose of our study was to evaluate the diagnostic and prognostic potential of this new imaging tool after processing of the image loops in patients with acute ischemic stroke. Subjects and Methods PatientsInclusion criteria were as follows: acute onset of sensorimotor hemiparesis, neglect or incomplete aphasia Յ40 hours before the initial investigation, and early stroke signs on cranial computed tomography (CCT) (focal hypoattenuation or focal brain swelling in the territory of the internal carotid artery, obscuration of basal ganglia, or hyperdense middle cerebral artery sign 10 ), as well as a sufficient acoustic bone window for conventional transcranial colorcoded sonography (TCCS). Exclusion criteria were as follows: intracranial hemorrhage detected by CCT and complete aphasia, pregnancy, and severe cardiac, pulmonary, or renal disease. All patients gave informed consent.By using the National Institutes of Health Stroke Scale (NIHSS) and the modified Rankin Score (mRS), the clinical status of the patients was assessed before the investigat...
In acute stroke, different sonographic methods can be used to assess structural and hemodynamic compromise. Structural abnormalities of brain parenchyma such as primary intracerebral hemorrhage (ICH) and epiphenomena such as midline shift can be detected by native transcranial B-mode ultrasound. Moreover, transcranial Doppler provides a functional approach to intracranial hemodynamics and may assist in predicting ICH growth and global intracranial pressure increase. New ultrasound technologies allow the visualization of ultrasound contrast agents in the cerebral microcirculation. According to recent data, ultrasound perfusion imaging provides additional information for the diagnosis of ICH and may differentiate ischemic from hemorrhagic stroke. This review summarizes the impact of these different transcranial ultrasound methods on diagnosis and monitoring of ICH.
Background and Purpose-We conducted this prospective study to evaluate the time course of hemorrhagic transformation (HT) and arterial recanalization in the early phase of ischemic stroke using transcranial sonography (TCS). Methods-Fifty-five patients with acute ischemic hemispheric stroke Ͻ32 hours after symptom onset were studied. A 2-MHz sector probe was used to evaluate brain tissue by TCS and basal cerebral arteries by transcranial color-coded sonography. Follow-up investigations were performed up to 6 days. Lesion size and localization were determined by cranial computed tomography. Results-Of 20 patients with HT, 18 displayed by computed tomography could be identified by TCS. In 1 patient, TCS provided a wrong positive result, and in another 2 patients with small cortical HT, a wrong negative result was provided (sensitivity 90.0%, specificity 97.4%). HT was detected in the first 60 hours after symptom onset in 62.5% of patients treated with tissue plasminogen activator in comparison to 33.3% without thrombolysis. Recanalization of middle cerebral artery occurred earlier in tissue plasminogen activator-treated patients compared to those without tissue plasminogen activator treatment (in the first 60 hours after symptom onset: 78.5% vs 50.0%, respectively; Pϭ0.34).There was a significant time difference between middle cerebral artery recanalization and HT occurrence (nϭ13, median time interval: 20 vs 60 hours; Pϭ0.035). Conclusions-Transcranial
BHI can detect disturbed perfusion in acute hemispheric stroke. In their ability to predict the development of an infarction, intensity-based parameters and FAMIS were determined to have a high sensitivity, and TTP was found to have a high PPV and specificity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.